Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $10,495 | 11 | 45.9% |
| Education | $6,256 | 3 | 27.4% |
| Food and Beverage | $6,107 | 106 | 26.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lima USA, Inc. | $9,072 | 10 | $0 (2019) |
| Arthrex, Inc. | $5,516 | 13 | $0 (2024) |
| SeaPearl Inc | $3,198 | 19 | $0 (2022) |
| Seapearl East, Inc | $1,723 | 13 | $0 (2024) |
| Fidia Pharma USA Inc. | $1,007 | 20 | $0 (2023) |
| Horizon Therapeutics plc | $469.44 | 19 | $0 (2023) |
| Horizon Pharma plc | $395.98 | 4 | $0 (2017) |
| Medtronic USA, Inc. | $340.43 | 11 | $0 (2017) |
| Stratus Medical, LLC | $285.15 | 2 | $0 (2023) |
| Boston Scientific Corporation | $139.61 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,376 | 18 | Seapearl East, Inc ($1,403) |
| 2023 | $1,058 | 13 | SeaPearl East, Inc ($320.59) |
| 2022 | $721.27 | 20 | Horizon Therapeutics plc ($222.19) |
| 2021 | $1,968 | 15 | SeaPearl Inc ($1,546) |
| 2020 | $361.58 | 5 | SeaPearl Inc ($304.54) |
| 2019 | $5,813 | 15 | Arthrex, Inc. ($4,542) |
| 2018 | $9,495 | 17 | Lima USA, Inc. ($8,922) |
| 2017 | $1,064 | 17 | Horizon Pharma plc ($395.98) |
All Payment Transactions
120 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | Seapearl East, Inc | — | Food and Beverage | In-kind items and services | $59.05 | General |
| 02/09/2024 | Seapearl East, Inc | — | Travel and Lodging | In-kind items and services | $427.35 | General |
| 02/03/2024 | Seapearl East, Inc | — | Food and Beverage | In-kind items and services | $62.52 | General |
| 02/03/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $24.00 | General |
| 02/03/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $10.00 | General |
| 02/03/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $10.00 | General |
| 02/03/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $5.00 | General |
| 02/02/2024 | Arthrex, Inc. | — | Travel and Lodging | In-kind items and services | $427.35 | General |
| 02/02/2024 | Seapearl East, Inc | — | Food and Beverage | In-kind items and services | $136.90 | General |
| 02/02/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $45.00 | General |
| 02/02/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $10.00 | General |
| 02/02/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $10.00 | General |
| 02/02/2024 | Seapearl East, Inc | — | Travel and Lodging | In-kind items and services | $7.01 | General |
| 02/02/2024 | Arthrex, Inc. | — | Food and Beverage | In-kind items and services | $5.00 | General |
| 02/01/2024 | Arthrex, Inc. | — | Travel and Lodging | In-kind items and services | $427.35 | General |
| 02/01/2024 | Seapearl East, Inc | — | Food and Beverage | In-kind items and services | $64.81 | General |
| 01/11/2024 | Seapearl East, Inc | — | Travel and Lodging | In-kind items and services | $542.35 | General |
| 01/11/2024 | Seapearl East, Inc | — | Food and Beverage | In-kind items and services | $102.53 | General |
| 11/24/2023 | SeaPearl East, Inc | — | Food and Beverage | In-kind items and services | $67.89 | General |
| 08/02/2023 | Stratus Medical, LLC | Nimbus (Device) | Food and Beverage | Cash or cash equivalent | $156.85 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 08/01/2023 | Stratus Medical, LLC | Nimbus (Device) | Food and Beverage | Cash or cash equivalent | $128.30 | General |
| Category: Neuro & Physical Medical Device | ||||||
| 07/13/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $107.63 | General |
| Category: KRYSTEXXA | ||||||
| 05/31/2023 | SeaPearl East, Inc | — | Food and Beverage | In-kind items and services | $66.64 | General |
| 04/18/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $104.67 | General |
| Category: KRYSTEXXA | ||||||
| 04/13/2023 | SeaPearl East, Inc | — | Food and Beverage | In-kind items and services | $50.89 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 202 | 368 | $80,871 | $32,037 |
| 2022 | 7 | 255 | 502 | $172,477 | $36,953 |
| 2021 | 8 | 235 | 404 | $119,314 | $34,939 |
| 2020 | 5 | 151 | 251 | $54,149 | $19,401 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 192 | $38,103 | $20,153 | 52.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $15,194 | $6,841 | 45.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 29 | 60 | $22,925 | $3,650 | 15.9% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 24 | 32 | $3,990 | $1,206 | 30.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 21 | 33 | $660.00 | $187.50 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 197 | $39,327 | $21,091 | 53.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 55 | 55 | $17,706 | $7,275 | 41.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 31 | 81 | $32,200 | $4,816 | 15.0% |
| 73562 | X-ray of knee, 3 views | Office | 2022 | 36 | 51 | $6,160 | $1,881 | 30.5% |
| J7322 | Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 2022 | 19 | 60 | $73,920 | $1,203 | 1.6% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2022 | 14 | 16 | $2,324 | $491.97 | 21.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 19 | 42 | $840.00 | $194.68 | 23.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 76 | 189 | $37,699 | $21,255 | 56.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 51 | 51 | $15,300 | $7,514 | 49.1% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 32 | 54 | $21,232 | $3,554 | 16.7% |
| 73562 | X-ray of knee, 3 views | Office | 2021 | 17 | 22 | $2,683 | $849.42 | 31.7% |
| J7322 | Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 2021 | 17 | 32 | $38,400 | $810.84 | 2.1% |
| 72100 | X-ray of lower and sacral spine, 2 or 3 views | Office | 2021 | 11 | 11 | $1,540 | $415.47 | 27.0% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2021 | 12 | 12 | $1,800 | $390.96 | 21.7% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 19 | 33 | $660.00 | $149.31 | 22.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 57 | 128 | $25,526 | $11,727 | 45.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 34 | 34 | $10,094 | $4,400 | 43.6% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 22 | 38 | $15,050 | $2,374 | 15.8% |
| 73560 | X-ray of knee, 1 or 2 views | Office | 2020 | 20 | 27 | $3,000 | $784.10 | 26.1% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 18 | 24 | $480.00 | $115.91 | 24.1% |
About Dr. Jason Baynes, MD
Dr. Jason Baynes, MD is a General Acute Care Hospital healthcare provider based in Englewood, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1720279243.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jason Baynes, MD has received a total of $22,858 in payments from pharmaceutical and medical device companies, with $2,376 received in 2024. These payments were reported across 120 transactions from 17 companies. The most common payment nature is "Travel and Lodging" ($10,495).
As a Medicare-enrolled provider, Baynes has provided services to 843 Medicare beneficiaries, totaling 1,525 services with total Medicare billing of $123,331. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty General Acute Care Hospital
- Location Englewood, NJ
- Active Since 08/08/2007
- Last Updated 11/19/2014
- Taxonomy Code 282N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1720279243
Products in Payments
- SMR (Device) $9,096
- HYMOVIS (Device) $717.60
- NO_PRODUCT (Drug) $395.98
- Nimbus (Device) $285.15
- VECTRIS (Device) $265.71
- KRYSTEXXA (Biological) $212.30
- Hymovis (Device) $180.87
- RAYOS (Drug) $164.80
- GENERAL PAIN MANAGEMENT (Device) $139.61
- Spinal-Stim (Device) $137.10
- Fibrinet (Biological) $125.41
- NEURAGEN (Device) $120.23
- Prometra II (Device) $116.09
- NuDyn (Biological) $108.11
- PENNSAID (Drug) $92.34
- ADAPTIVESTIM (Device) $74.72
- RELIGN (Device) $52.83
- Connected Health-MyMobility (Device) $40.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.